President’s letter
2020 Metrics
Cycle of Translation
Visionary Gifts
Discovery to Clinic
Innovative Education
Translational Luminaries
Introduction
The Ann Kimbell and John W. Johnson Center for Cellular Therapeutics
The Fondren Food & Health Alliance and The Fondren Inflammation Center
Cockrell Center for Advanced Therapeutics
Paula and Joseph C. “Rusty” Walter III Translational Research Initiative
Jerold B. Katz Academy of Translational Research
result
Outcomes Research
Precision Medicine
CPRIT Funding to Drive New Discoveries in Cancer Therapeutics
Siemens Healthineers and Houston Methodist Imaging Innovation Hub Empowers Researchers to Push the Boundaries
Novel Monoclonal Antibody Treatment Halts Tumor Growth in Deadly Ovarian and Pancreatic Cancers
Houston Methodist Institute for Technology, Innovation & Education (MITIESM)
Can Devices Provide A New Treatment Option for Glioblastoma?
Houston Methodist Hospital’s new Paula and Joseph C. “Rusty” Walter III Tower offers the Most advanced treatments and innovations available
Neuroimaging Offers New Insights into Neurodegeneration
COVID-19 Studies
Restorative Medicine
Houston Methodist and Rice University Launch Center for Translational Neural Prosthetics and Interfaces
Non-invasive Spinal Stimulation Enables Paralyzed People to Stand Unassisted
Dissolvable Implants Enhance the Body’s Ability to Heal Broken Bones
Cell Encapsulation May Hold the Key to Preventing Cell Transplant Rejection
Revolutionizing the Future of Complex Valve Disease Management
Science in Service
of
Medicineresult
President's letter
2020 Metrics
Cycle of Translation
Visionary Gifts of Hope
Introduction
The Ann Kimbell and John W. Johnson Center for Cellular Therapeutics
The Fondren Food & Health Alliance and The Fondren Inflammation Center
Cockrell Center for Advanced Therapeutics
Paula and Joseph C. “Rusty” Walter III Translational Research Initiative
Jerold B. Katz Academy of Translational Research
From Discovery to Clinic
Introduction
Restorative Medicine
Houston Methodist and Rice University Launch Center for Translational Neural Prosthetics and Interfaces
Non-invasive Spinal Stimulation Enables Paralyzed People to Stand Unassisted
Dissolvable Implants Enhance the Body’s Ability to Heal Broken Bones
Cell Encapsulation May Hold the Key to Preventing Cell Transplant Rejection
Revolutionizing the Future of Complex Valve Disease Management
Precision Medicine
CPRIT Funding to Drive New Discoveries in Cancer Therapeutics
An Innovative New Tool to Enable Drug Discovery and Personalized Medicine
Devising a Novel Combination Treatment for Aggressive Double-hit Lymphoma
Expanding the RNAcore to Encompass the Entire Cycle of a Cure
Siemens Healthineers and Houston Methodist Imaging Innovation Hub Empowers Researchers to Push the Boundaries
Novel Monoclonal Antibody Treatment Halts Tumor Growth in Deadly Ovarian and Pancreatic Cancers
Houston Methodist Institute for Technology, Innovation & Education (MITIESM)
Surgical Technology Developed in MITIE Gains FDA Approval
Pushing the Frontier of the Robotics Revolution
Can Devices Provide A New Treatment Option for Glioblastoma?
Houston Methodist Hospital’s new Paula and Joseph C. “Rusty” Walter III Tower offers the Most advanced treatments and innovations available
Neuroimaging Offers New Insights into Neurodegeneration
Translational Luminaries
Discovery to Clinic
Precision Medicine
Houston Methodist Hospital’s new Paula and Joseph C. “Rusty” Walter III Tower offers the Most advanced treatments and innovations available
Houston Methodist Hospital’s new Paula and Joseph C. “Rusty” Walter III Tower offers the
Most advanced treatments and innovations available
Houston Methodist’s Paula and Joseph C. “Rusty” Walter III Tower is home to sophisticated neurological and cardiovascular surgical suites specially designed for highly technical and minimally invasive image-guided procedures.
Through the Siemens consortium, the Walter Tower and MITIESM have been outfitted with triple hybrid surgical suites that integrate robotic-assisted technology with the most advanced CT, angiography and MRI technology available as well as a dual CT and PET scanner that can illuminate specific biochemical processes in order to provide precise, efficient and safe surgeries for our patients and advance our clinical research endeavors.
01
New Virtual Intensive Care Unit Simultaneously Improves Patient Care and Bed Capacity
The coronavirus pandemic has escalated a digital transformation within intensive care units where remote monitoring technologies enable professionals to more efficiently and safely manage their patients.
When the pandemic began, Houston Methodist accelerated the timeline for completing ongoing virtual ICU programming and construction. In March of 2020, we launched a comprehensive virtual ICU system that utilizes specifically tailored remote clinical surveillance and data analytics platforms as well as interactive video conferencing.
The virtual ICU system has provided a great advantage to health care providers during the COVID-19 pandemic as it reduces the amount of direct patient interaction needed, thereby limiting PPE use and potential exposure to pathogens. At the same time, virtual ICU system increases the number of patients that can be cared for simultaneously and empowers clinical staff to provide earlier interventions.
The virtual ICU provides continuous intensivist coverage for Houston Methodist’s 300+ ICU beds, offering additional support to bedside ICU teams. The virtual unit’s operations center is equipped with specialized software that captures and analyzes real-time clinical data to calculate each patient’s stability or risk of deterioration, allowing the team to anticipate events and act quickly. Each of the ICU rooms are equipped with a virtual alert button so that the bedside team can immediately alert the remote intensivist and nurses. The patient rooms also contain two-way audiovisual technologies for unobtrusive observation or communication between the patient, bedside team and virtual team. Houston Methodist has also deployed tablets for health care providers to perform “virtual rounds” on patients.
More from Discovery to Clinic